What is Cinvanti ?

Cinvanti (aprepitant) is an injectable medication used in the prevention of nausea and vomiting associated with cancer chemotherapy, including highly emetogenic (high risk of causing vomiting) chemotherapy regimens. It functions as a substance P/neurokinin 1 (NK1) receptor antagonist, effectively blocking the action of a key neurotransmitter involved in triggering nausea and vomiting reflexes. Cinvanti is generally utilized as part of a combination therapy to enhance antiemetic efficacy.

• Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
• Lightheadedness, dizziness, or fainting
• Blistering, peeling, or red skin rash

• Tell your doctor if you are breastfeeding, or if you have liver disease or blood clotting problems.
• It is not safe to take this medicine during pregnancy. It could harm an unborn baby. Tell your doctor right away if you become pregnant. Birth control (including pills, rings, implants and other devices) may not work as well to prevent pregnancy when used with this medicine. Use another form of birth control that does not contain hormones (including condoms or spermicide) along with your pills. Use an effective form of birth control during treatment with this medicine and for 1 month after the last dose.
• Your doctor will check your progress and the effects of this medicine at regular visits. Keep all appointments.